HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review
Annals of Cancer Research and Therapy · 2026 · 34 (2) · 65-73
DOI: 10.4993/acrt.34.65 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2026. Verfasst von Ahmed Sohaib. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sohaib, A. (2026). HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review. Annals of Cancer Research and Therapy, 34(2), 65-73. https://doi.org/10.4993/acrt.34.65
Vancouver
Sohaib A. HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review. Annals of Cancer Research and Therapy. 2026;34(2):65-73. doi:10.4993/acrt.34.65
BibTeX
@article{Sohaib2026,
author = {Sohaib, Ahmed},
title = {HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review},
journal = {Annals of Cancer Research and Therapy},
year = {2026},
volume = {34},
number = {2},
pages = {65--73},
doi = {10.4993/acrt.34.65}
}
EUVIMED